Table 1 Demographics of patients with DN
| Â | DN | Control |
|---|---|---|
n | 6 | 3 |
Age (years) | 51.7 ± 7.8 | 46.5 ± 6.7 |
Sex (male) | 5 | 2 |
Smoking (%) | 28.6 | 33.3 |
Duration of diabetes (years) | 7.3 ± 5.3 | 0 |
Duration of DN (months) | 12.1 ± 11.5 | 0 |
Diabetic retinopathy (n) | 2 | 0 |
HbA1c (%) | 7.5 ± 0.8 | 6.3 ± 0.4 |
Hemoglobin (g/L) | 117.4 ± 30.1 | 132.5 ± 10.5 |
Serum albumin (g/L) | 31.4 ± 9.9 | 46.5 ± 4.7 |
Serum creatinine(umol/L) | 133.0 ± 60.8 | 77.4 ± 12.6 |
eGFR (ml/min) | 62.2 ± 21.3 | 108.5 ± 14.8 |
TG (mmol/L) | 1.7 ± 1.2 | 2.1 ± 0.7 |
CHOL (mmol/L) | 5.4 ± 1.3 | 5.8 ± 1.1 |
HDL (mmol/L) | 1.5 ± 0.4 | 1.4 ± 0.5 |
LDL (mmol/L) | 3.2 ± 1.1 | 3.3 ± 1.3 |
Urinary protein excretion (g/24 h) | 3.5 ± 2.0 | 0.062 ± 0.013 |
Mogensen stage of DN (n) [20] | Â | Â |
 Stage IV | 5 | 0 |
 Stage V | 1 | 0 |
Pathologic classification of DN (n) [21] | Â | Â |
 Class 2 | 2 | 0 |
 Class 3 | 2 | 0 |
 Class 4 | 2 | 0 |